BioLineRx Ltd. (BLRX)
NASDAQ: BLRX · Real-Time Price · USD
2.487
-0.043 (-1.70%)
At close: Sep 18, 2026, 4:00 PM EDT
2.540
+0.053 (2.13%)
After-hours: Sep 18, 2026, 7:30 PM EDT

BioLineRx Revenue

BioLineRx had revenue of $294.00K in the quarter ending June 30, 2026, a decrease of -3.29%. This brings the company's revenue in the last twelve months to $1.39M, down -91.93% year-over-year. In the year 2025, BioLineRx had annual revenue of $1.18M, down -95.92%.

Revenue (ttm)
$1.39M
Revenue Growth
-91.93%
P/S Ratio
8.08
Revenue / Employee
$58,000
Employees
24
Market Cap
11.24M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20251.18M-27.76M-95.92%
Dec 31, 202428.94M24.14M502.92%
Dec 31, 20234.80M--
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Immuron5.34M
Vistagen Therapeutics2.50M
Daré Bioscience1.37M
CytoMed Therapeutics669.28K
Azitra7.50K
Revenue Rankings